Telemedicine in the Healthcare Delivery System
Arkansas Health Executives Forum Panel
1.5 ACHE Face-to-Face Hours Provided
Per ACHE guidelines, attendance is limited to 60 with priority given to in-state members.
Telemedicine has become a healthcare access imperative. Its innovative benefits are of vital interest amid the implementation of most healthcare regulations and of great importance as the COVID-19 pandemic continues. Telemedicine uses a
variety of forms of electronic communication technology to provide a convenient method to deliver healthcare services and
education. This panel will discuss its current uses and organizational deployment of telemedicine. The discussion includes
adoption and innovation across clinical and patient perspective. Technical, operational, regulatory, and financial/
reimbursement aspects of the development of telemedicine programs will be investigated. The expanding role that telemedicine holds in daily medicine and its direction into the future of the healthcare delivery system will be explored.
Bo Ryall, President & CEO, Arkansas Hospital Association
Christopher DeBernard, MD, CMO, Arisa Health
Mia Bartuska Finkelston, MD, Senior Medical Director, AmWell Medical Group
Christy Hockaday, FACHE, VP, Provider Network Innovation and Strategy, Arkansas Blue Cross Blue Shield
Mark Jansen, MD, VP and CMO, Arkansas Blue Cross Blue Shield
Darren Sommer, DO, MBA, MPH, FACOI, FHM, CPE, CEO and Founder, Deck V